S&P 500
6,005.88
+0.1%
+$5.52
DJI
42,761.76
-0.0%
-$1.11
NASDAQ
19,591.24
+0.3%
+$61.28
Bitcoin
109,209.00
+3.6%
+3,769.18
AAPL
$201.70
-1.1%
-$2.22
AMZN
$217.31
+1.8%
+$3.74
GOOG
$177.80
+1.8%
+$3.09
META
$694.90
-0.4%
-$2.81
MSFT
$472.66
+0.5%
+$2.28
NVDA
$142.74
+0.7%
+$1.02
TSLA
$308.41
+4.5%
+$13.27
Acelyrin (NASDAQ: SLRN)
Some price data may be temporarily unavailable.
Acelyrin Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Acelyrin Company Info
ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.
News & Analysis
Featured Article
Highest-Paid CEOs in 2025
You'll be shocked to learn how much these executives earn annually.
Catherine Brock | Nov 8, 2023
Featured Article
Why Acelyrin Stock Plummeted 59% This Week
The recently public biopharma company announced disappointing results from a clinical trial of its lead drug candidate.
Steve Symington | Sep 15, 2023
Valuation
Earnings Transcripts
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.